← Leaderboards
Garrett M Brodeur
Children'S Hospital Of Philadelphia
$23,136,915
Attributed
$24,666,298
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$24,666,298 · 7
By mechanism
R01$10,950,191 · 3
P01$10,813,950 · 2
T32$2,547,498 · 1
P30$354,659 · 1
Top collaborators
- Michael Chorny5 shared
Most similar at Children'S Hospital Of Philadelphia
Same institution · by research overlap
- Carolyn A Felix$7,871,940
- Beverly J Lange$1,518,442
Others in their field
Top investigators on “Neuroblastoma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Gregory H Reaman · National Childhood Cancer Foundation$84,462,747
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$58,436,699
- Larry Arthur$30,516,306
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
NeuroblastomaChildLeadBiologicalMalignant Childhood NeoplasmCell LineTumorCancer TherapyToxic EffectProgramsMycn GeneAdverse EffectsMalignant NeoplasmsSignal TransductionClinical ResearchAcuteGeneticDesignTranslatingCellsHigh RiskPathogenesisLigandsSolid Neoplasm
Grant awards (50)
Prodrugs targeting norepinephrine transporter for dual-selective therapy of refractory neuroblastoma$591,818
R01 · FY2024 · CA
Prodrugs targeting norepinephrine transporter for dual-selective therapy of refractory neuroblastoma$610,508
R01 · FY2023 · CA
Prodrugs targeting norepinephrine transporter for dual-selective therapy of refractory neuroblastoma$610,508
R01 · FY2022 · CA
Prodrugs targeting norepinephrine transporter for dual-selective therapy of refractory neuroblastoma$622,966
R01 · FY2021 · CA
Prodrugs targeting norepinephrine transporter for dual-selective therapy of refractory neuroblastoma$622,966
R01 · FY2020 · CA
Pediatric Oncology Research Program$7,213
P30 · FY2019 · CA · contact PI
Pediatric Oncology Research Program$5,768
P30 · FY2019 · CA · contact PI
Pediatric Oncology Research Program$3,627
P30 · FY2019 · CA · contact PI
Pediatric Oncology Research Program$1,106
P30 · FY2019 · CA · contact PI
Pediatric Oncology Research Program$181,092
P30 · FY2018 · CA · contact PI
Pediatric Oncology Research Program$9,404
P30 · FY2018 · CA · contact PI
Pediatric Oncology Research Program$2,510
P30 · FY2018 · CA · contact PI
Pediatric Oncology Research Program$2,143
P30 · FY2018 · CA · contact PI
Pediatric Oncology Research Program$70,898
P30 · FY2017 · CA · contact PI
Pediatric Oncology Research Program$70,898
P30 · FY2016 · CA · contact PI
Molecular Genetic Analysis of Human Neuroblastoma$354,521
R01 · FY2013 · CA · contact PI
Molecular Genetic Analysis of Human Neuroblastoma$377,150
R01 · FY2012 · CA · contact PI
Trk Expression and Inhibition in Human Neuroblastomas$366,503
R01 · FY2012 · CA · contact PI
Molecular Genetic Analysis of Human Neuroblastoma$377,150
R01 · FY2011 · CA · contact PI
Trk Expression and Inhibition in Human Neuroblastomas$369,828
R01 · FY2011 · CA · contact PI
Molecular Genetic Analysis of Human Neuroblastoma$388,815
R01 · FY2010 · CA · contact PI
Trk Expression and Inhibition in Human Neuroblastomas$387,333
R01 · FY2010 · CA · contact PI
Molecular Genetic Analysis of Human Neuroblastoma$388,815
R01 · FY2009 · CA · contact PI
Trk Expression and Inhibition in Human Neuroblastomas$378,136
R01 · FY2009 · CA · contact PI
Trk Expression and Inhibition in Human Neuroblastomas$367,942
R01 · FY2008 · CA · contact PI
Neuroblastoma Biology and Therapy$2,216,467
P01 · FY2007 · CA · contact PI
Cancer center research training program$290,998
T32 · FY2007 · CA · contact PI
Neuroblastoma Biology and Therapy$2,120,863
P01 · FY2006 · CA · contact PI
Molecular Genetic Analysis of Human Neuroblastoma$390,112
R01 · FY2006 · CA · contact PI
Effect of Trk Expression and Inhibition in Neuroblastoma$369,361
R01 · FY2006 · CA · contact PI
Cancer center research training program$312,260
T32 · FY2006 · CA · contact PI
Neuroblastoma Biology and Therapy$2,139,824
P01 · FY2005 · CA
Molecular Genetic Analysis of Human Neuroblastoma$399,500
R01 · FY2005 · CA
Effect of Trk Expression and Inhibition in Neuroblastoma$378,250
R01 · FY2005 · CA
Cancer center research training program$351,009
T32 · FY2005 · CA
Neuroblastoma Biology and Therapy$2,090,796
P01 · FY2004 · CA
Molecular Genetic Analysis of Human Neuroblastoma$399,500
R01 · FY2004 · CA
Effect of Trk Expression and Inhibition in Neuroblastoma$378,250
R01 · FY2004 · CA
CANCER RESEARCH TRAINING PROGRAM$365,795
T32 · FY2004 · CA
Neuroblastoma Biology and Therapy$2,003,090
P01 · FY2003 · CA
Molecular Genetic Analysis of Human Neuroblastoma$394,395
R01 · FY2003 · CA
Effect of Trk Expression and Inhibition in Neuroblastoma$378,250
R01 · FY2003 · CA
CANCER RESEARCH TRAINING PROGRAM$342,647
T32 · FY2003 · CA
Effect of Trk Expression and Inhibition in Neuroblastoma$367,036
R01 · FY2002 · CA
CANCER RESEARCH TRAINING PROGRAM$318,317
T32 · FY2002 · CA
MOLECULAR GENETIC ANALYSIS OF HUMAN NEUROBLASTOMA$343,831
R01 · FY2001 · CA
CANCER RESEARCH TRAINING PROGRAM$275,861
T32 · FY2001 · CA
MOLECULAR GENETIC ANALYSIS OF HUMAN NEUROBLASTOMA$336,747
R01 · FY2000 · CA
CANCER RESEARCH TRAINING PROGRAM$290,611
T32 · FY2000 · CA
NEUROTROPHIN AND TRK EXPRESSION IN MEDULLOBLASTOMA AND NEUROBLASTOMA$242,910
P01 · FY2000 · NS